Trigeminal Central Pain is a chronic facial pain caused by damage to the brain or brainstem pathways that carry signals from the trigeminal nerve. Unlike trigeminal neuralgia—which comes from a nerve root compression—central pain arises when the central nervous system itself is injured, for example after a stroke, multiple sclerosis, or spinal cord injury. Patients feel ongoing, often burning or shooting pain in one or more branches of the trigeminal nerve (the fifth cranial nerve), which supplies sensation to the forehead, cheeks, and jaw. Because the damage is in the brain or spinal cord, the pain can be more constant and harder to control than other facial pain syndromes.
Trigeminal central pain is a form of chronic neuropathic facial pain that arises when the pathways carrying sensory input from the face to the brain are damaged within the central nervous system (CNS). Unlike trigeminal neuralgia—which is caused by irritation or compression of the peripheral trigeminal nerve—this pain originates from lesions in structures such as the brainstem, thalamus, or higher cortical regions that process facial sensation. Patients describe it as a constant burning, squeezing, or pins-and-needles sensation in the areas served by one or more branches of the fifth cranial (trigeminal) nerve. Episodes of sudden, brief electric-shock–like pain may occur on top of the continuous discomfort, but these are not the main feature. Because it stems from central lesions, trigeminal central pain often resists standard treatments for peripheral nerve pain and may require specialized management. ichd-3.orgncbi.nlm.nih.gov
Types of Trigeminal Central Pain
-
Central Post-Stroke Trigeminal Pain
When a stroke affects the thalamus or brainstem nuclei that relay facial sensations, patients can develop a continuous, burning pain in the face opposite to the damaged side. This “central post-stroke pain” often appears weeks to months after the vascular event and may be accompanied by temperature dysesthesia and allodynia. ncbi.nlm.nih.gov -
Multiple Sclerosis–Related Trigeminal Central Pain
Demyelinating plaques in the pons or entry zone of the trigeminal nerve within the CNS can trigger facial neuropathic pain. In MS, this manifests as paroxysms of electric-shock–like attacks over a background of constant dysesthetic pain. Dedicated MRI often shows pontine plaques near the trigeminal root entry zone. thejournalofheadacheandpain.biomedcentral.comichd-3.org -
Tumor-Induced Central Trigeminal Pain
Intracranial tumors—such as gliomas, meningiomas, or metastases—in or near the trigeminal nucleus or its ascending tracts can produce a continuous facial burning or gnawing sensation. Pressure on second-order neurons may also give rise to superimposed lancinating pains. ihs-headache.org -
Iatrogenic Central Trigeminal Pain
Surgical interventions on the brainstem or posterior fossa (for example, microvascular decompression) can unintentionally injure central trigeminal pathways, leading to persistent neuropathic pain in the treated dermatome despite successful relief of the original condition. trigeminalnerve.org.uk -
Traumatic Brain Injury–Related Central Trigeminal Pain
Head injuries that damage the brainstem or thalamic trigeminal tracts can produce prolonged facial pain syndromes. Patients often report constant aching or burning pain beginning days to weeks after the trauma, sometimes accompanied by facial numbness and altered thermal perception. ihs-headache.org
Causes
-
Thalamic Infarction (Dejerine–Roussy Syndrome)
A stroke confined to the ventroposterior nucleus of the thalamus disrupts the relay of pain and temperature fibers, causing contralateral facial burning and hyperalgesia. -
Brainstem (Pontine) Stroke
Infarction in the pons can injure second-order trigeminal neurons, leading to continuous facial dysesthesia. -
Multiple Sclerosis Plaques
Demyelination near the trigeminal root entry zone in the pons produces mixed paroxysmal and continuous pain. -
Glioma or Meningioma
Tumors compressing or infiltrating the trigeminal sensory nuclei or tracts generate a neuropathic pain pattern. -
Traumatic Brain Injury
Direct injury to central trigeminal pathways causes a delayed onset neuropathic pain in the innervated regions. -
Surgical Lesions
Neurosurgical procedures near the trigeminal nucleus may inadvertently damage central fibers. -
Radiation Injury
Radiotherapy to the skull base or brainstem may induce central demyelination and subsequent pain. -
Central Pontine Myelinolysis
Osmotic shifts leading to demyelination in the pons can involve trigeminal fibers. -
Neurosarcoidosis
Granulomatous inflammation in the brainstem can injure trigeminal nuclei. -
Brain Abscess or Infection
Infections affecting the pons or midbrain may produce post-infectious central pain. -
Hemorrhagic Stroke
Brainstem or thalamic hemorrhage disrupts sensory pathways. -
Vascular Malformations
Arteriovenous malformations in the brainstem can irritate central trigeminal fibers. -
Neurodegenerative Disease (e.g., Parkinson’s)
Central neurodegeneration may alter pain processing pathways. -
Amyotrophic Lateral Sclerosis
Rarely, central motor and sensory tract degeneration in ALS involves trigeminal fibers. -
Neuromyelitis Optica
Demyelination in optic pathways may extend to trigeminal central tracts. -
Central Tumor Metastasis
Secondary tumors settling in the thalamus or brainstem. -
Autoimmune Encephalitis
Inflammatory damage to CNS sensory nuclei. -
Metabolic Disorders (e.g., Diabetes with Central Involvement)
Central small-fiber neuropathy contributing to facial pain. -
Central Lesions from Lyme Disease
Neuroborreliosis affecting the trigeminal nucleus. -
Post–Intracranial Hematoma
Residual mass effect or gliosis impinging on central trigeminal pathways. ncbi.nlm.nih.govthejournalofheadacheandpain.biomedcentral.com
Symptoms
-
Constant Burning Pain
A steady burning sensation in the cheek, jaw, or forehead area. -
Pins-and-Needles (Paresthesia)
Tingly or prickling feelings across the face. -
Allodynia
Pain from light touch—such as washing or shaving the face. -
Hyperalgesia
Exaggerated pain response to mildly painful stimuli (e.g., pinprick). -
Electric-Shock Paroxysms
Brief, sudden jolts of electric-like pain over a background of burning. -
Sharp Stabbing Pain
Quick, knife-like pains that last seconds to minutes. -
Squeezing or Pressure Sensation
Feeling of tightness or squeezing in facial regions. -
Temperature Dysesthesia
Abnormal sensitivity to hot or cold, often painful. -
Facial Numbness
Regions of reduced sensation accompanying pain. -
Throbbing Ache
Rhythmic, heartbeat-like sensations in painful areas. -
Spontaneous Pain
Pain occurring without any apparent trigger. -
Emotional Distress
Anxiety or depression arising from unrelenting facial pain. -
Sleep Disturbance
Difficulty falling or staying asleep because of pain. -
Jaw Spasms
Involuntary tightening of masticatory muscles. -
Eye Pain or Discomfort
Pain extending around the eye or temple. -
Headache
Dull or throbbing head pain accompanying facial symptoms. -
Tearing or Eye-Watering
Reflex lacrimation due to pain. -
Difficulty Chewing or Speaking
Fear of triggering pain may limit jaw movement. -
Sensitivity to Wind
Air currents across the face provoke pain. -
Facial Weakness (Occasional)
Mild motor deficits in chronic cases. ncbi.nlm.nih.govncbi.nlm.nih.gov
Diagnostic Tests
Physical Exam
-
Neurological Sensory Mapping
Testing light touch, pinprick, and temperature across V1–V3 dermatomes to pinpoint abnormal areas of sensation. ncbi.nlm.nih.gov -
Corneal Reflex Testing
A gentle touch to the cornea elicits a blink; delayed or absent response signals trigeminal pathway involvement. ncbi.nlm.nih.gov -
Jaw Jerk Reflex
Tapping the chin lightly should provoke a slight jaw closure; hyperreflexia suggests central lesions. ncbi.nlm.nih.gov -
Facial Muscle Inspection
Observing for atrophy or spasms in muscles of mastication. ncbi.nlm.nih.gov -
Thermal Sensitivity Test
Applying warm and cool stimuli to facial skin to detect dysesthesia. ncbi.nlm.nih.gov -
Vibratory Sense Examination
Using a tuning fork across the face to assess large-fiber function. ncbi.nlm.nih.gov -
Trigger Point Palpation
Pressing known trigger zones to reproduce paroxysmal pain. ncbi.nlm.nih.gov -
Functionality of Jaw Opening/Closing
Evaluating range of motion and pain provocation during movement. ncbi.nlm.nih.gov
Manual Tests
-
Palpation of Trigeminal Ganglion Area
Gently pressing over the foramen ovale region to assess tenderness. ncbi.nlm.nih.gov -
Temporal Muscle Palpation
Feeling for tenderness or spasms over the temple. ncbi.nlm.nih.gov -
Masseter Muscle Palpation
Checking for pain or tightness when palpating the cheek. ncbi.nlm.nih.gov -
Mandibular Protrusion Test
Asking the patient to push the lower jaw forward against resistance. ncbi.nlm.nih.gov -
Mandibular Retrusion Test
Directing the patient to pull the lower jaw back while assessing for pain. ncbi.nlm.nih.gov -
Dental Percussion
Lightly tapping teeth to rule out odontogenic pain referral. ncbi.nlm.nih.gov -
Facial Trigger Maneuvers
Simulating daily activities (e.g., washing face) to reproduce symptoms. ncbi.nlm.nih.gov -
Palpation of Supraorbital and Infraorbital Rims
Assessing for focal tenderness along V1 and V2 branches. ncbi.nlm.nih.gov
Lab & Pathological Tests
-
Complete Blood Count (CBC)
Screening for infection or systemic inflammation that could contribute to neuropathy. ncbi.nlm.nih.gov -
Erythrocyte Sedimentation Rate (ESR) & C-Reactive Protein (CRP)
Evaluating for underlying inflammatory diseases. ncbi.nlm.nih.gov -
Antinuclear Antibody (ANA) Panel
Detecting autoimmune conditions (e.g., lupus) that may involve CNS. ncbi.nlm.nih.gov -
Lyme Serology
Ruling out neuroborreliosis as a cause of central neuropathic pain. ncbi.nlm.nih.gov -
Vitamin B12 Level
Excluding nutritional deficiencies that affect myelin integrity. ncbi.nlm.nih.gov -
Blood Glucose/HbA1c
Assessing for diabetes-related neuropathies. ncbi.nlm.nih.gov -
Cerebrospinal Fluid Analysis
Looking for oligoclonal bands in MS or markers of infection/inflammation. ncbi.nlm.nih.gov -
Autoimmune Encephalitis Panel
Testing for anti-neuronal antibodies in suspected inflammatory cases. ncbi.nlm.nih.gov
Electrodiagnostic Tests
-
Blink Reflex Study
Recording electromyographic responses in orbicularis oculi after supraorbital nerve stimulation to localize lesions. ncbi.nlm.nih.gov -
Trigeminal Somatosensory Evoked Potentials (TSEPs)
Measuring cortical responses to trigeminal nerve stimulation. ncbi.nlm.nih.gov -
Nerve Conduction Studies of Facial Muscles
Assessing the integrity of efferent trigeminal fibers. ncbi.nlm.nih.gov -
Electromyography (EMG) of Masticatory Muscles
Detecting denervation or reinnervation patterns. ncbi.nlm.nih.gov -
Laser-Evoked Potentials
Evaluating small fiber (Aδ) function in the trigeminal distribution. ncbi.nlm.nih.gov -
Quantitative Sensory Testing (QST)
Psychophysical assessment of sensory thresholds for warmth, cold, and vibration. ncbi.nlm.nih.gov -
Magnetoencephalography (MEG)
Mapping cortical responses to trigeminal stimuli in research settings. ncbi.nlm.nih.gov -
Brainstem Auditory Evoked Potentials (BAEPs)
Occasionally used to assess adjacent brainstem function. ncbi.nlm.nih.gov
Imaging Tests
-
High-Resolution Brain MRI (Trigeminal Protocol)
Identifying lesions in the brainstem, thalamus, or trigeminal root entry zone. my.clevelandclinic.org -
MR Angiography
Visualizing vascular malformations or microvascular compression. my.clevelandclinic.org -
Diffusion Tensor Imaging (DTI) & Tractography
Mapping integrity of central trigeminal pathways. my.clevelandclinic.org -
CT Scan of Brainstem
Detecting hemorrhage or calcified lesions affecting trigeminal tracts. my.clevelandclinic.org -
Positron Emission Tomography (FDG-PET)
Assessing metabolic changes in central pain structures. my.clevelandclinic.org -
Single-Photon Emission CT (SPECT)
Evaluating regional cerebral blood flow alterations in central pain syndromes. my.clevelandclinic.org -
Ultrasound-Guided Foramen Ovale Injection
Primarily therapeutic, but ultrasound may visualize foramen relations. my.clevelandclinic.org -
Functional MRI (fMRI)
Research tool to study pain-related brain activity. my.clevelandclinic.org
Non-Pharmacological Treatments
Physiotherapy & Electrotherapy Therapies
-
Transcutaneous Electrical Nerve Stimulation (TENS)
Uses: Small electrodes on the skin deliver mild electrical currents to “block” pain signals.
Mechanism: Stimulates large sensory fibers to inhibit the smaller pain fibers in the spinal cord, reducing the perception of pain. -
Interferential Current Therapy
Uses: Two medium-frequency currents intersect under the skin to create a low-frequency effect in deep tissues.
Mechanism: Helps drive pain-blocking currents deeper into facial muscles and nerve pathways, easing central sensitization. -
High-Voltage Pulsed Current (HVPC)
Uses: Short pulses of high-voltage, twin-peak currents promote healing and reduce pain.
Mechanism: Stimulates blood flow, enhances tissue repair, and modulates nerve excitability. -
Ultrasound Therapy
Uses: High-frequency sound waves generate deep heat to relax tissues.
Mechanism: Increases blood flow, reduces muscle spasm around the jaw and face, and can interrupt pain feedback loops. -
Low-Level Laser Therapy
Uses: Non-heat laser light applied to the skin’s surface.
Mechanism: Promotes cellular repair and reduces inflammation in nerve tissues. -
Neurodynamic Mobilization
Uses: Slow, gentle stretching of nerve tissue through guided movements.
Mechanism: Restores normal sliding of nerve roots, decreasing mechanical irritation in the brainstem. -
Cryotherapy (Cold Packs)
Uses: Application of cold to painful facial areas for 10–15 minutes.
Mechanism: Temporarily numbs nerve endings and slows pain signal transmission. -
Heat Therapy
Uses: Warm pack or moist heat over the jaw and cheek for 10–20 minutes.
Mechanism: Increases local blood flow, relaxes tight muscles, and soothes pain. -
Massage Therapy
Uses: Gentle pressure and kneading of facial and neck muscles.
Mechanism: Relieves muscular tension that can amplify central pain signals. -
Myofascial Release
Uses: Sustained pressure over tight facial connective tissue.
Mechanism: Loosens adhesions and restores normal sensory input. -
Biofeedback Training
Uses: Sensors monitor muscle tension or skin temperature and display it on a screen.
Mechanism: Teaches patients to voluntarily control muscle relaxation or blood flow to reduce pain. -
Mirror Therapy
Uses: A mirror reflects the non-painful side of the face while the patient moves the painful side.
Mechanism: “Tricks” the brain to remap sensory pathways, reducing phantom or central pain. -
Manual Joint Mobilization
Uses: Gentle gliding movements of the jaw joint by a trained therapist.
Mechanism: Restores normal joint mechanics, reducing secondary muscle overactivity. -
Orofacial Myofunctional Therapy
Uses: Exercises and soft-tissue techniques to balance facial muscles.
Mechanism: Improves muscle tone and proprioceptive input to central pathways. -
Galvanic Stimulation
Uses: Direct current through electrodes placed on the painful area.
Mechanism: Alters nerve membrane potential to decrease hyperexcitability.
Exercise Therapies
-
Aerobic Exercise
Uses: Walking, cycling, or swimming for 20–30 minutes most days.
Mechanism: Releases endorphins (natural pain blockers) and reduces central sensitization. -
Facial Stretching Exercises
Uses: Gentle stretches of jaw, cheeks, and forehead muscles.
Mechanism: Maintains muscle flexibility and decreases trigger points. -
Jaw Strengthening Exercises
Uses: Isometric jaw-hold against gentle resistance.
Mechanism: Improves muscular support and reduces strain on nerve pathways. -
Neck and Shoulder Stabilization
Uses: Exercises for deep neck flexors and shoulder retractors.
Mechanism: Ensures proper head posture, minimizing abnormal nerve tension. -
Gentle Yoga
Uses: Poses focusing on neck and upper-body alignment.
Mechanism: Promotes relaxation, reduces stress, and improves blood flow to cranial tissues.
Mind-Body Therapies
-
Cognitive Behavioral Therapy (CBT)
Uses: Works with a psychologist to reframe unhelpful thoughts about pain.
Mechanism: Reduces emotional distress and central amplification of pain signals. -
Mindfulness Meditation
Uses: Focused breathing and body scans for 10–20 minutes daily.
Mechanism: Enhances cognitive control over pain perception by changing brain activity. -
Guided Imagery
Uses: Visualization of calming scenes or “cooling” imagery on the face.
Mechanism: Shifts attention away from pain and activates pain-inhibiting brain networks. -
Progressive Muscle Relaxation
Uses: Tensing and then relaxing each muscle group, including the face.
Mechanism: Counteracts the muscle-tension–pain cycle common in central pain. -
Hypnotherapy
Uses: A trained therapist induces a trance to suggest decreased pain.
Mechanism: Modifies pain-processing pathways in the brain for lasting relief.
Educational Self-Management
-
Pain Education Workshops
Uses: Group classes on how central pain works and coping strategies.
Mechanism: Knowledge reduces fear and catastrophic thinking, lowering pain intensity. -
Self-Monitoring Diaries
Uses: Daily logs of pain level, triggers, and coping tactics.
Mechanism: Empowers patients to identify and avoid personal triggers. -
Paced Activity Planning
Uses: Scheduling periods of activity and rest to avoid “boom-and-bust” cycles.
Mechanism: Prevents overactivity that worsens central sensitization. -
Trigger Identification Training
Uses: Guided analysis of weather, foods, stressors that worsen pain.
Mechanism: Tailors self-management to each patient’s unique pattern. -
Coping Skills Coaching
Uses: One-on-one sessions to build problem-solving and relaxation skills.
Mechanism: Enhances resilience and reduces emotional amplification of pain.
Evidence-Based Drugs
-
Carbamazepine (Tegretol)
• Class: Sodium-channel blocker (antiepileptic)
• Dosage: Start 100 mg twice daily, increase to 200 mg three times daily as tolerated
• Time: Take with food, morning and evening
• Side Effects: Dizziness, drowsiness, nausea, risk of low sodium levels -
Oxcarbazepine (Trileptal)
• Class: Sodium-channel blocker
• Dosage: 150 mg twice daily, up to 600 mg twice daily
• Time: With meals
• Side Effects: Headache, fatigue, hyponatremia -
Gabapentin (Neurontin)
• Class: Gabapentinoid
• Dosage: 300 mg at night, up to 300 mg three times daily
• Time: Titrate over days
• Side Effects: Weight gain, dizziness, edema -
Pregabalin (Lyrica)
• Class: Gabapentinoid
• Dosage: 75 mg twice daily, up to 150 mg twice daily
• Time: Morning and evening
• Side Effects: Drowsiness, dry mouth, blurred vision -
Lamotrigine (Lamictal)
• Class: Antiepileptic
• Dosage: Start 25 mg daily, increase every two weeks to 100–200 mg daily
• Time: Once daily
• Side Effects: Rash (rare but serious), headache -
Amitriptyline (Elavil)
• Class: Tricyclic antidepressant
• Dosage: 10 mg at bedtime, up to 75 mg at bedtime
• Time: Night (satiety reduces side effects)
• Side Effects: Dry mouth, constipation, drowsiness -
Nortriptyline (Pamelor)
• Class: Tricyclic antidepressant
• Dosage: 10 mg at bedtime, up to 50 mg
• Time: Night
• Side Effects: Similar to amitriptyline but milder -
Duloxetine (Cymbalta)
• Class: SNRI antidepressant
• Dosage: 30 mg once daily, may increase to 60 mg
• Time: Morning with food
• Side Effects: Nausea, insomnia, increased sweating -
Venlafaxine (Effexor XR)
• Class: SNRI
• Dosage: 37.5 mg once daily, up to 150 mg
• Time: Morning
• Side Effects: Hypertension, headache -
Memantine (Namenda)
• Class: NMDA-receptor antagonist
• Dosage: 5 mg once daily, up to 20 mg daily
• Time: Morning or evening
• Side Effects: Dizziness, headache -
Ketamine Infusion
• Class: NMDA antagonist
• Dosage: 0.5 mg/kg over 40 minutes IV
• Time: Infusion sessions weekly or as directed
• Side Effects: Dissociation, increased heart rate -
Intravenous Lidocaine
• Class: Sodium-channel blocker
• Dosage: 1–2 mg/kg IV infusion over one hour
• Time: In clinic under monitoring
• Side Effects: Drowsiness, lightheadedness -
Clonazepam (Klonopin)
• Class: Benzodiazepine
• Dosage: 0.25 mg at bedtime, up to 2 mg daily
• Time: Bedtime (reduces morning sedation)
• Side Effects: Sedation, risk of dependence -
Baclofen (Lioresal)
• Class: Muscle relaxant (GABA-B agonist)
• Dosage: 5 mg three times daily, up to 20 mg three times daily
• Time: With meals
• Side Effects: Weakness, drowsiness -
Topical Lidocaine 5% Patch
• Class: Local anesthetic
• Dosage: Apply patch to painful area for up to 12 hours/day
• Time: On for 12 hours, off for 12 hours
• Side Effects: Skin irritation -
Capsaicin 8% Patch
• Class: TRPV1 agonist (desensitizing)
• Dosage: Single 60-minute application every 3 months
• Time: In clinic under anesthesia
• Side Effects: Local burning -
Botulinum Toxin Type A
• Class: Neuromodulator
• Dosage: 50–100 units injected per session
• Time: Every 12 weeks
• Side Effects: Injection pain, temporary muscle weakness -
Nabiximols (Sativex)
• Class: Cannabis extract (THC/CBD)
• Dosage: 1–3 sprays per day, titrate to effect
• Time: Throughout the day
• Side Effects: Dizziness, dry mouth -
Mexiletine (Mexitil)
• Class: Oral antiarrhythmic (sodium-channel blocker)
• Dosage: 200 mg three times daily
• Time: With meals
• Side Effects: GI upset, tremor -
Gabapentin Enacarbil (Horizant)
• Class: Prodrug of gabapentin
• Dosage: 600 mg once daily
• Time: Evening
• Side Effects: Similar to gabapentin
Dietary Molecular Supplements
-
Alpha-Lipoic Acid
• Dosage: 600 mg daily
• Function: Antioxidant that protects nerves from free-radical damage
• Mechanism: Restores normal nerve conduction and reduces inflammation -
Acetyl-L-Carnitine
• Dosage: 500 mg twice daily
• Function: Supports mitochondrial energy in nerve cells
• Mechanism: Promotes nerve regeneration and myelin repair -
Curcumin (Turmeric Extract)
• Dosage: 500 mg three times daily with black pepper
• Function: Anti-inflammatory and pain-modulating
• Mechanism: Inhibits NF-κB and reduces pro-inflammatory cytokines -
Omega-3 Fatty Acids (Fish Oil)
• Dosage: 1,000 mg EPA/DHA daily
• Function: Anti-inflammatory, membrane stabilizing
• Mechanism: Alters eicosanoid production to reduce nerve inflammation -
Vitamin B12 (Methylcobalamin)
• Dosage: 1,000 mcg daily
• Function: Essential for myelin maintenance
• Mechanism: Supports nerve myelin sheath repair -
Vitamin D3
• Dosage: 2,000 IU daily
• Function: Neuroprotective and anti-inflammatory
• Mechanism: Modulates cytokines and nerve growth factors -
Magnesium Glycinate
• Dosage: 200 mg elemental magnesium nightly
• Function: NMDA-receptor modulation
• Mechanism: Reduces central sensitization by blocking excitatory receptors -
Coenzyme Q10
• Dosage: 100 mg twice daily
• Function: Mitochondrial support in neurons
• Mechanism: Enhances ATP production and reduces oxidative stress -
N-Acetylcysteine (NAC)
• Dosage: 600 mg twice daily
• Function: Precursor to glutathione ( antioxidant )
• Mechanism: Protects nerves from oxidative injury -
Resveratrol
• Dosage: 250 mg daily
• Function: Anti-inflammatory and neuroprotective
• Mechanism: Activates SIRT1 pathways, reducing neuronal apoptosis
Advanced Regenerative & Specialty Drugs
-
Alendronate (Fosamax)
• Class: Bisphosphonate
• Dosage: 70 mg once weekly
• Function: Reduces bone-related pain where trigeminal bone pathology contributes
• Mechanism: Inhibits osteoclasts, decreasing bone turnover -
Recombinant Human Nerve Growth Factor
• Class: Regenerative biologic
• Dosage: Under investigation (in clinical trial settings)
• Function: Promotes nerve fiber repair
• Mechanism: Binds TrkA receptors, stimulating axonal growth -
Platelet-Rich Plasma (PRP) Injections
• Class: Autologous regenerative therapy
• Dosage: 3–5 mL injected monthly for 3 months
• Function: Concentrated growth factors accelerate nerve healing
• Mechanism: Releases PDGF, TGF-β, and VEGF at injury sites -
Hyaluronic Acid Injection
• Class: Viscosupplementation
• Dosage: 1 mL injected into the temporomandibular joint weekly for 3 weeks
• Function: Cushions joint to reduce secondary pain amplification
• Mechanism: Restores synovial fluid viscosity and joint lubrication -
Botulinum Toxin Type A (Advanced Regenerative Use)
• Class: Neuromodulator/regenerative adjunct
• Dosage: 100–150 units per session every 3 months
• Function: Reduces nociceptive signaling long-term
• Mechanism: Inhibits release of substance P and CGRP from neurons -
Mesenchymal Stem Cell Therapy
• Class: Stem-cell regenerative
• Dosage: Autologous cells injected into trigeminal nucleus region (experimental)
• Function: Potential to replace or repair damaged central neurons
• Mechanism: Releases trophic factors and may differentiate into neural cells -
Recombinant Human Bone Morphogenetic Protein-2
• Class: Growth factor
• Dosage: Experimental implants at central lesion sites
• Function: Encourages neural tissue scaffolding
• Mechanism: Stimulates local stem cell differentiation -
NGF Antagonist (Tanezumab)
• Class: Monoclonal antibody
• Dosage: 10 mg IV infusion every 8 weeks (investigational)
• Function: Blocks nerve growth factor to reduce pain sensitization
• Mechanism: Prevents NGF binding to TrkA, reducing nociceptor activation -
Recombinant Human Erythropoietin (NeuroEPO)
• Class: Neuroprotective biologic
• Dosage: 10,000 IU daily intranasal (research setting)
• Function: Promotes neural survival and repair
• Mechanism: Activates EPO receptors on neurons, reducing apoptosis -
Stem-Cell-Derived Exosome Therapy
• Class: Regenerative extracellular vesicles
• Dosage: Under clinical study (IV or intrathecal)
• Function: Delivers growth factors and miRNAs to injured neurons
• Mechanism: Modulates inflammation and promotes neuroregeneration
Surgical Options
-
Microvascular Decompression (MVD)
Procedure: Neurosurgeon places a small Teflon pad between a compressing vessel and the trigeminal root.
Benefits: Offers long-term relief by removing blood-vessel pulsation on the nerve. -
Stereotactic Radiosurgery (Gamma Knife)
Procedure: High-dose, focused radiation targets the trigeminal root entry zone.
Benefits: Non-invasive, outpatient procedure with gradual pain relief. -
Percutaneous Balloon Compression
Procedure: A catheter with a small balloon compresses the trigeminal ganglion through the cheek.
Benefits: Immediate pain relief, can be repeated if needed. -
Glycerol Rhizotomy
Procedure: Glycerol is injected around the trigeminal ganglion to chemically injure pain fibers.
Benefits: Minimally invasive, outpatient, quick recovery. -
Radiofrequency Thermocoagulation
Procedure: A thin electrode delivers heat to selectively damage pain fibers.
Benefits: Adjustable lesion size for tailored pain control. -
Trigeminal Nerve Combing
Procedure: Fine cuts made in the trigeminal root to disrupt pain signals.
Benefits: Preserves some touch sensation while reducing pain. -
Neurectomy
Procedure: Partial surgical removal of a branch of the trigeminal nerve.
Benefits: Last-resort option when other treatments fail, can eliminate pain. -
Dorsal Root Entry Zone (DREZ) Lesioning
Procedure: Lesioning of the spinal trigeminal nucleus in the brainstem.
Benefits: Targets central pain pathways directly for severe cases. -
Deep Brain Stimulation (DBS)
Procedure: Electrodes implanted in pain-processing regions (thalamus, periaqueductal gray).
Benefits: Adjustable stimulation parameters; reversible. -
Motor Cortex Stimulation
Procedure: Electrodes placed on the skull over the motor cortex corresponding to facial area.
Benefits: Modulates pain networks indirectly with fewer sensory side effects.
Prevention Strategies
-
Early Treatment of Central Lesions
Treat stroke or MS flares promptly to limit nerve damage. -
Good Control of Blood Sugar
In diabetics, prevents small-fiber neuropathy that can worsen central pain. -
Blood Pressure Management
Reduces risk of brainstem or thalamic strokes that cause central pain. -
Regular Exercise
Maintains healthy blood flow and nerve resilience. -
Stress Reduction
Chronic stress raises central sensitization; manage with relaxation. -
Protective Headgear
In high-risk activities, to prevent head injury and subsequent central damage. -
Balanced Diet
Rich in antioxidants and anti-inflammatory nutrients (omega-3s, vitamins). -
Good Sleep Hygiene
Adequate rest helps the brain repair nerve injury. -
Avoidance of Repetitive Facial Strain
Limits secondary muscle tension that feeds pain loops. -
Regular Neurological Check-Ups
Early detection of central lesions can guide preventive measures.
When to See a Doctor
Seek medical attention if you experience:
-
New, constant burning or stabbing facial pain that does not improve with home care
-
Weakness in facial muscles or changes in sensation
-
Sudden worsening after a stroke or head injury
-
Signs of infection (fever, swelling) around injection sites
-
Severe side effects from medications (e.g., confusion, severe rash)
“Do’s” and “Don’ts”
Do:
-
Keep a detailed pain diary to track patterns.
-
Apply warm or cool packs as directed by your therapist.
-
Practice daily relaxation or mindfulness exercises.
-
Maintain good posture to reduce facial and neck tension.
-
Attend all physiotherapy and counseling sessions.
Don’t:
-
Skip doses of your prescribed medications.
-
Expose your face to extreme cold without protection.
-
Overuse opioids or benzodiazepines without supervision.
-
Push through pain with unmonitored strenuous activity.
-
Ignore new neurological symptoms—report them promptly.
Frequently Asked Questions
-
What causes trigeminal central pain?
It arises from damage in the brain or brainstem pathways—often due to stroke, multiple sclerosis, or spinal cord injury—leading to chronic abnormal pain signaling. -
How is it different from trigeminal neuralgia?
Neuralgia is caused by nerve-root compression and produces brief, stabbing attacks. Central pain is constant, burning, and comes from central lesions. -
Can it be cured?
There is no cure for nerve injury in the brain, but many treatments can significantly reduce pain and improve quality of life. -
Are non-drug therapies really effective?
Yes. Combining physiotherapy, exercise, and mind-body techniques often enhances the effect of medications by retraining the nervous system. -
Which drug is best?
Carbamazepine and oxcarbazepine are first-line. However, individual response varies, so your doctor may adjust choices. -
Are there risks with long-term pain drugs?
Some drugs can cause sedation, low sodium, or blood pressure changes. Regular monitoring by your doctor is important. -
What dietary supplements help nerve pain?
Alpha-lipoic acid, acetyl-L-carnitine, and B vitamins have good evidence for nerve support and pain reduction. -
When should I consider surgery?
Surgery is an option if your pain is severe, disabling, and not controlled by less invasive treatments. -
Is exercise safe?
Yes, gentle, guided exercise reduces central sensitization. High-impact sports may worsen symptoms. -
Can stress make pain worse?
Absolutely. Stress heightens central pain pathways, so learning relaxation is crucial. -
What is mirror therapy?
It’s a technique where a mirror “fools” your brain into seeing painless movement, which can reduce central pain signals. -
Are stem-cell treatments approved?
Most are experimental. They show promise in clinical trials but aren’t yet standard care. -
How long until I see improvement?
You may notice decreased pain within weeks of starting therapy, but optimal relief often takes months of combined treatments. -
Will I become dependent on pain medications?
Most antiepileptics and antidepressants have low addiction risk. Benzodiazepines and opioids carry higher risks and need careful management. -
Where can I find support?
Ask your clinic about pain-management support groups—sharing experiences can improve coping and outcomes.
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: June 23, 2025.